Omeros Corporation

OMER· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$12.56+6.08%

2026-08-03

Financials

Valuation Metrics

Omeros Corporation's Market Cap is $909M. At end of 2025 it was $1.14B. Ranked #2565 of 3,111 in US market (top 82%), #1070 of 1,445 on NASDAQ (top 74%), #200 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 74%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$909M	US#2,565/3,111 Sec#200/269
Revenue	$10M	US#2,930/3,111 Sec#182/269
Net Income	$86M	US#1,662/3,111 Sec#59/269
Total Assets	$286M	US#2,919/3,111 Sec#220/269
Net Assets	$86M	US#2,895/3,111 Sec#232/269
Value
P/E	10.55x	US#258/3,111 Sec#11/269
P/B	10.61x	US#2,624/3,111 Sec#205/269
P/S	91.89x	US#2,910/3,111 Sec#179/269
EV/EBITDA	13.11x	US#1,154/3,111 Sec#37/269
FCF Yield	-10.43%	US—/3,111 Sec—/269
Profitability
ROE	100.57%	US#28/3,111 Sec#2/269
ROA	30.11%	US#27/3,111 Sec#7/269
Op. Margin	-1063.86%	US#2,930/3,111 Sec#180/269
Financial Health
Debt Ratio	407.90%	US#2,302/3,111 Sec#230/269
Total Debt	$311M	US#2,055/3,111 Sec#75/269
FCF	$-95M	US#2,584/3,111 Sec#147/269
Cash	$2M	US#3,044/3,111 Sec#272/269
Current Ratio	3.03x	US#798/3,111 Sec#195/269
Net Debt/EBITDA	3.32x	US#1,710/3,111 Sec#73/269
Performance
1Y Return	247.92%	US#94/3,111 Sec#32/269
1M Return	35.34%	US#65/3,111 Sec#7/269
From 52W High	-28.84%	US#2,224/3,111 Sec#170/269
1Y MDD	-49.53%	US#2,385/3,111 Sec#185/269
Trading
Volume	1,435,234 shares	US#1,206/3,111 Sec#109/269
Trading Value	$18M	US#2,095/3,111 Sec#160/269
Per Share
EPS	$-1.36	US—/3,111 Sec—/269